Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
McKinsey
Medtronic
Mallinckrodt

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR SITAGLIPTIN PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Sitagliptin Phosphate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00086515 ↗ Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2004-06-30 The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00127192 ↗ A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) Completed Merck Sharp & Dohme Corp. Phase 2 2005-07-01 The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with type 2 diabetes mellitus.
NCT00289848 ↗ MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040) Completed Merck Sharp & Dohme Corp. Phase 3 2006-03-01 This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00305604 ↗ Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2006-03-08 To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.
NCT00363519 ↗ Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus Completed Ono Pharmaceutical Co. Ltd Phase 3 2006-08-01 The purpose of this study is to determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy and glimepiride as monotherapy
NCT00363844 ↗ Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus Completed Ono Pharmaceutical Co. Ltd Phase 3 2006-08-01 Determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sitagliptin Phosphate

Condition Name

Condition Name for Sitagliptin Phosphate
Intervention Trials
Type 2 Diabetes Mellitus 17
Type 2 Diabetes 8
Diabetes Mellitus, Non-Insulin-Dependent 4
Diabetes Mellitus 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sitagliptin Phosphate
Intervention Trials
Diabetes Mellitus, Type 2 31
Diabetes Mellitus 31
Hypoglycemia 1
Obesity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sitagliptin Phosphate

Trials by Country

Trials by Country for Sitagliptin Phosphate
Location Trials
United States 18
Japan 3
China 2
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sitagliptin Phosphate
Location Trials
New York 2
Colorado 2
Nevada 1
Michigan 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sitagliptin Phosphate

Clinical Trial Phase

Clinical Trial Phase for Sitagliptin Phosphate
Clinical Trial Phase Trials
Phase 4 4
Phase 3 18
Phase 2 2
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sitagliptin Phosphate
Clinical Trial Phase Trials
Completed 38
Unknown status 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sitagliptin Phosphate

Sponsor Name

Sponsor Name for Sitagliptin Phosphate
Sponsor Trials
Merck Sharp & Dohme Corp. 32
Ono Pharmaceutical Co. Ltd 3
University of Colorado, Denver 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sitagliptin Phosphate
Sponsor Trials
Industry 37
Other 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Baxter
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.